CLOs on the Move

EyeCare Services Partners

www.espmgmt.com

 
EyeCare Services Partners (ESP) provides ownership and practice management of ophthalmologic, optometric and ambulatory surgery centers nationwide. ESP offers eye care providers and ambulatory surgery center owners compelling and effective solutions for today`s constantly changing healthcare environment. Utilization of our resources and expertise eliminates the stress of practice management. We are creating the nation`s leading eyecare services company in both quality and scale by consolidating ophthalmologic and optometric practices and ambulatory surgery centers that are locally dominant and clinically differentiated. We provide a patient centric model that delivers outstanding care and quality outcomes through our providers and staff by leveraging ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.espmgmt.com
  • 2727 North Harwood Street Suite 350
    Dallas, TX USA 75201
  • Phone: 844.377.6468

Executives

Name Title Contact Details
Theresa Bissonnette
Vice President of Compliance and Quality Profile

Similar Companies

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

Sauk Prairie Memorial Hospital

Sauk Prairie Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Prairie Du Sac, WI. To find more information about Sauk Prairie Memorial Hospital, please visit www.spmh.org

Eisenhower Medical Center

Eisenhower Medical Center was founded over 30 years ago based on a vision of excellence. It is our personal mission to sustain this vision by making Five Star Treatment for Everyone a day-to-day reality — not just a slogan.

CenterCare Inc

CenterCare Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Trust RCM

Trust RCM is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.